Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AbbVie
Age
12–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Documented clinical diagnosis of non-segmented vitiligo (NSV).
At Screening and Baseline Visits, participants must satisfy at least 1 of the following criteria:
* \>= 0.5 F-VASI and 5 \<= T-VASI \< 50 AND have failed at least 1 topical corticosteroid and/or at least 1 topical calcineurin inhibitor for vitiligo; or
* \>= 0.5 F-VASI and 5 \<= T-VASI \< 50 AND have a sign of actively progressing vitiligo; or
* \>= 0.5 F-VASI and 10 \<= T-VASI \< 50.
You may not be if
Segmental or localized vitiligo.
History of active skin disease other than vitiligo that could interfere with the assessment of vitiligo.
\>33% leukotrichia in areas of vitiligo on the face or \> 33% leukotrichia in areas of vitiligo on the body (including the face).
Clareo Health | A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Participants With Vitiligo
